Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Clinical trial NCT01903733 · COMPLETED
Trial details
- NCT number
- NCT01903733
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-28
- Primary completion
- 2020-06-05
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.